共 4 条
[1]
Newby K, 2001, CIRCULATION, V103, P1727
[2]
Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events post-acute cOroNary syndromes (SYMPHONY) trial
[J].
AMERICAN HEART JOURNAL,
1999, 138 (02)
:210-218
[4]
Topol CE, 2000, LANCET, V355, P337

